ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation.

Karaki, H

ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. [electronic resource] - European journal of pharmacology Feb 1993 - 371-4 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0014-2999

10.1016/0014-2999(93)90112-u doi


Animals
Drug Interactions
Endothelin Receptor Antagonists
Endothelins--pharmacology
Endothelium, Vascular--drug effects
Male
Muscle Contraction--drug effects
Muscle Relaxation--drug effects
Muscle, Smooth, Vascular--drug effects
Nitric Oxide--metabolism
Peptide Fragments--pharmacology
Rats
Rats, Wistar